Position
Chief Scientific Officer
Company
Enodia Therapeutics
ParisBiotechnologyTherapeuticsDescription
Enodia Therapeutics has appointed Dr. Yvonne McGrath as Chief Scientific Officer to enhance their targeted protein degradation platform. With over 25 years of experience, Dr
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel (April 14, 2026)
- Juvisé Pharmaceuticals Appoints Renaud Sermondade as CEO (April 16, 2026)
- Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer (April 16, 2026)
- CG Oncology Appoints Jim DeTore as Chief Financial Officer (April 13, 2026)
- NRx Pharmaceuticals Appoints Glenn Tyson as Chief Commercial Officer (April 13, 2026)
- ABIVAX Appoints Michael Nesrallah as Chief Commercial Officer (April 12, 2026)
Who to call at Enodia Therapeutics, and when
A new leader at Enodia Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Enodia Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Enodia Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Enodia Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Enodia Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Enodia Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.